Thymia

Thymia is a London-based health technology startup that uses artificial intelligence (AI) to monitor and assess mental health. The company operates in the healthcare and wellness sector, serving healthcare providers, insurance companies, and employers. Thymia's business model revolves around the use of engaging games to identify and track mental health biomarkers, making mental health visible and measurable.

The company's AI models are unique as they combine three types of data: voice, video, and behavioural data. This multi-modal approach, developed by their team of scientists, significantly increases the accuracy and robustness of their assessments. Each type of data is linked to different symptoms, providing specific insights into a person's mental health.

Thymia offers two product ranges: Helios and Apollo. Helios, set to launch in 2024, focuses on mental wellness indicators such as mental strain, burnout, stress, and confidence. Apollo, currently available as an investigational device, provides insights into major mental health conditions like depression, anxiety, and ADHD.

The company makes money by selling their services to healthcare providers, insurance companies, and employers who want to understand and address mental health issues in their patients or employees. Thymia's innovative approach to mental health assessment and monitoring has the potential to revolutionize the way mental health is understood and treated.

Keywords: Health Technology, Mental Health, Artificial Intelligence, Biomarkers, Healthcare Providers, Insurance Companies, Employers, Wellness, Depression, Anxiety.